Ben Zion Katz

Title: The Innovative Contributions of Ben Zion Katz

Introduction

Ben Zion Katz is a notable inventor based in Rehovot, Israel. He has made significant contributions to the field of cancer treatment through his innovative work on T-cells. His research focuses on the development of T-cells that can target specific cancer antigens, which has the potential to improve therapeutic outcomes for patients.

Latest Patents

Katz holds a patent for "T-cells comprising two different chimeric antigen receptors and uses thereof." This invention provides T-cells modified to express at least two chimeric antigen receptors. One of the CARs binds specifically to an antigen selected from CD138, HER2, and CD24, while another CAR binds specifically to a different antigen from the same group. The invention also includes pharmaceutical compositions comprising these CAR T-cells and their use in the treatment of cancer, particularly ovarian cancer. Additionally, it covers DNA constructs encoding the CARs and methods for preparing T-cells that express these CARs. Katz has 1 patent to his name.

Career Highlights

Throughout his career, Katz has worked with prominent organizations, including the Medical Research Infrastructure and Health Services Fund of the Tel Aviv Medical Center and Yeda Research and Development Company. His work has been instrumental in advancing the understanding and treatment of cancer through innovative cellular therapies.

Collaborations

Katz has collaborated with esteemed colleagues such as Zelig Eshhar and Tova Waks. Their combined expertise has contributed to the development of groundbreaking research in the field of immunotherapy.

Conclusion

Ben Zion Katz's innovative work in the field of T-cell therapy represents a significant advancement in cancer treatment. His contributions continue to inspire further research and development in this critical area of medicine.